Spinnaker Trust Abb Vie Inc. Transaction History

Spinnaker Trust

$1.61 Billion
Q3 2024

A detailed history of Spinnaker Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, Spinnaker Trust holds 15,509 shares of ABBV stock, worth $2.79 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

15,509

Previous 15,991 3.01%

Holding current value

$2.79 Million

Previous $2.74 Million 11.67%

% of portfolio

0.19%

Previous 0.18%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $78,970 - $96,077	-482 Reduced 3.01%	15,509 $3.06 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $2,716 - $3,095	-17 Reduced 0.11%	15,991 $2.91 Million
Q4 2023 Feb 02, 2024	SELL	$137.6 - $154.97 $41,280 - $46,491	-300 Reduced 1.84%	16,008 $2.48 Million
Q3 2023 Nov 08, 2023	BUY	$133.59 - $154.65 $43,683 - $50,570	327 Added 2.05%	16,308 $2.43 Million
Q2 2023 Aug 01, 2023	BUY	$132.51 - $164.9 $27,827 - $34,629	210 Added 1.33%	15,981 $2.15 Million
Q1 2023 Apr 13, 2023	SELL	$144.61 - $166.54 $6,652 - $7,660	-46 Reduced 0.29%	15,771 $2.51 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $34,577 - $41,467	-250 Reduced 1.56%	15,817 $2.56 Million
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $6,710 - $7,696	-50 Reduced 0.31%	16,067 $2.16 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $5,229 - $6,648	-38 Reduced 0.24%	16,117 $2.47 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $46,456 - $57,640	-352 Reduced 2.13%	16,155 $2.62 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $107,430 - $135,930	1,000 Added 6.45%	16,507 $2.24 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $46,284 - $52,539	435 Added 2.89%	15,507 $1.67 Million
Q2 2021 Aug 09, 2021	SELL	$105.21 - $117.21 $1,998 - $2,226	-19 Reduced 0.13%	15,072 $1.7 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $45,523 - $50,115	445 Added 3.04%	15,091 $1.63 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $23,797 - $27,929	277 Added 1.93%	14,646 $1.28 Million
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $11,812 - $15,806	-161 Reduced 1.11%	14,369 $1.41 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $22,510 - $34,128	-349 Reduced 2.35%	14,530 $1.11 Million
Q4 2019 Feb 05, 2020	SELL	$72.13 - $90.25 $137,263 - $171,745	-1,903 Reduced 11.34%	14,879 $1.32 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $66,129 - $79,506	1,050 Added 6.67%	16,782 $1.27 Million
Q2 2019 Jul 11, 2019	BUY	$65.7 - $83.98 $6,241 - $7,978	95 Added 0.61%	15,732 $1.14 Million
Q4 2018 Feb 04, 2019	BUY	$77.85 - $96.01 $673,013 - $830,006	8,645 Added 123.64%	15,637 $1.44 Million
Q3 2018 Oct 23, 2018	SELL	$88.91 - $98.84 $93,355 - $103,782	-1,050 Reduced 13.06%	6,992 $661,000
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $199,845 - $267,612	2,172 Added 37.0%	8,042 $761,000
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $111,950 - $122,762	1,250 Added 27.06%	5,870 $567,000
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $322,707 - $412,196	4,620	4,620 $410,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spinnaker Trust, based on Form 13F filings with the SEC.

News

Stay updated on Spinnaker Trust with notifications on news.

Account